RSAD2 and cervical cancer: Notably, lower RSAD2 expression appeared to be linked to worse cervical cancer prognosis (Figure 7g), while low IFIT1 expression was also associated with poorer survival, though its predictive power was not statistically significant (Figure 7h, p > 0.05).